Compare PLBC & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLBC | AGL |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.6M | 270.4M |
| IPO Year | 2005 | 2021 |
| Metric | PLBC | AGL |
|---|---|---|
| Price | $47.00 | $0.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 18 |
| Target Price | ★ $55.00 | $2.79 |
| AVG Volume (30 Days) | 21.5K | ★ 9.9M |
| Earning Date | 01-14-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | $89,868,000.00 | ★ $5,885,571,000.00 |
| Revenue This Year | $21.11 | N/A |
| Revenue Next Year | $16.11 | $3.40 |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | ★ 12.51 | 5.21 |
| 52 Week Low | $38.71 | $0.51 |
| 52 Week High | $49.47 | $6.08 |
| Indicator | PLBC | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 55.03 |
| Support Level | $43.50 | $0.65 |
| Resistance Level | $47.03 | $0.74 |
| Average True Range (ATR) | 0.79 | 0.05 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 77.94 | 92.10 |
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.